Regentis Biomaterials Ltd.
RGNT
AMEX·Healthcare·Medical - Instruments & Supplies·Mkt cap $13.8M
$1.88
▲ +3.86%
P/E
—
Mkt Cap
$13.8M
52-Wk Range
$1.23–$15.50
52-Week Range
$1.23 - $15.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 75.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta -0.7).
Growth
No forward estimates available
Value
Valuation data unavailable
Momentum
Falling
-60.4% over 3m
Quality
Below
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying RGNT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Earnings recap unavailable for this period.
Reported EPS · last 4Q
No quarterly earnings data on file.
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How RGNT stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.